213 related articles for article (PubMed ID: 16982211)
1. Ubiquitin: tool and target for intracellular NF-kappaB inhibitors.
Wullaert A; Heyninck K; Janssens S; Beyaert R
Trends Immunol; 2006 Nov; 27(11):533-40. PubMed ID: 16982211
[TBL] [Abstract][Full Text] [Related]
2. Insights from vaccinia virus into Toll-like receptor signalling proteins and their regulation by ubiquitin: role of IRAK-2.
Bowie AG
Biochem Soc Trans; 2008 Jun; 36(Pt 3):449-52. PubMed ID: 18481979
[TBL] [Abstract][Full Text] [Related]
3. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
[TBL] [Abstract][Full Text] [Related]
4. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes.
Karin M; Gallagher E
Immunol Rev; 2009 Mar; 228(1):225-40. PubMed ID: 19290931
[TBL] [Abstract][Full Text] [Related]
5. The role of ubiquitin in NF-kappaB regulatory pathways.
Skaug B; Jiang X; Chen ZJ
Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
[TBL] [Abstract][Full Text] [Related]
6. Dynamic protein complexes regulate NF-kappaB signaling.
Wegener E; Krappmann D
Handb Exp Pharmacol; 2008; (186):237-59. PubMed ID: 18491055
[TBL] [Abstract][Full Text] [Related]
7. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling.
Chen F; Du Y; Zhang Z; Chen G; Zhang M; Shu HB; Zhai Z; Chen D
Cell Signal; 2008 Apr; 20(4):666-74. PubMed ID: 18234474
[TBL] [Abstract][Full Text] [Related]
8. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
Schmid JA; Birbach A
Cytokine Growth Factor Rev; 2008 Apr; 19(2):157-65. PubMed ID: 18308615
[TBL] [Abstract][Full Text] [Related]
9. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
10. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
11. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells.
Paimela T; Ryhänen T; Mannermaa E; Ojala J; Kalesnykas G; Salminen A; Kaarniranta K
Immunol Lett; 2007 Jun; 110(2):139-44. PubMed ID: 17532054
[TBL] [Abstract][Full Text] [Related]
12. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.
Carmody RJ; Chen YH
Cell Mol Immunol; 2007 Feb; 4(1):31-41. PubMed ID: 17349209
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
Lauder SN; Carty SM; Carpenter CE; Hill RJ; Talamas F; Bondeson J; Brennan P; Williams AS
Rheumatology (Oxford); 2007 May; 46(5):752-8. PubMed ID: 17218328
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB modulators in osteolytic bone diseases.
Xu J; Wu HF; Ang ES; Yip K; Woloszyn M; Zheng MH; Tan RX
Cytokine Growth Factor Rev; 2009 Feb; 20(1):7-17. PubMed ID: 19046922
[TBL] [Abstract][Full Text] [Related]
17. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
Tahan F; Jazrawi E; Moodley T; Rovati GE; Adcock IM
Clin Exp Allergy; 2008 May; 38(5):805-11. PubMed ID: 18325031
[TBL] [Abstract][Full Text] [Related]
18. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.
Yates LL; Górecki DC
Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636
[TBL] [Abstract][Full Text] [Related]
19. Signaling to NF-kappaB by Toll-like receptors.
Kawai T; Akira S
Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
[TBL] [Abstract][Full Text] [Related]
20. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.
Gringhuis SI; den Dunnen J; Litjens M; van Het Hof B; van Kooyk Y; Geijtenbeek TB
Immunity; 2007 May; 26(5):605-16. PubMed ID: 17462920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
